Association of QCT Bone Mineral Density and Bone Structure With Vertebral Fractures in Patients With Multiple Myeloma

被引:22
作者
Borggrefe, Jan [1 ,2 ]
Giravent, Sarah [1 ]
Thomsen, Felix [1 ,3 ]
Pena, Jaime [1 ]
Campbell, Graeme [1 ]
Wulff, Asmus [1 ]
Guenther, Andreas [4 ]
Heller, Martin [1 ]
Glueer, Claus C. [1 ]
机构
[1] Univ Clin Schleswig Holstein, Sect Biomed Imaging, Dept Radiol & Neuroradiol, Kiel, Germany
[2] Univ Clin Cologne, Inst Diagnost & Intervent Radiol, Cologne, Germany
[3] Natl Univ South, Dept Engn, Bahia Blanca, Buenos Aires, Argentina
[4] Univ Clin Schleswig Holstein, Sect Immun & Stemcell Therapy, Dept Inner Med, Kiel, Germany
关键词
MULTIPLE MYELOMA; OSTEOPOROSIS; VERTEBRAL FRACTURE; QCT; FRACTURE RISK; TRABECULAR SEPARATION; BMD; QUANTITATIVE COMPUTED-TOMOGRAPHY; FINITE-ELEMENT-ANALYSIS; CONVENTIONAL RADIOGRAPHY; WHOLE-BODY; CT; STRENGTH; THERAPY; RISK; MICROSTRUCTURE; THALIDOMIDE;
D O I
10.1002/jbmr.2443
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Computed tomography (CT) is used for staging osteolytic lesions and detecting fractures in patients with multiple myeloma (MM). In the OsteoLysis of Metastases and Plasmacell-infiltration Computed Tomography 2 study (OLyMP-CT) study we investigated whether patients with and without vertebral fractures show differences in bone mineral density (BMD) or microstructure that could be used to identify patients at risk for fracture. We evaluated whole-body CT scans in a group of 104 MM patients without visible osteolytic lesions using an underlying lightweight calibration phantom (Image Analysis Inc., Columbia, KY, USA). QCT software (StructuralInsight) was used for the assessment of BMD and bone structure of the T-11 or T-12 vertebral body. Age-adjusted standardized odds ratios (sORs) per SD change were derived from logistic regression analyses, and areas under the receiver operating characteristics (ROC) curve (AUCs) analyses were calculated. Forty-six of the 104 patients had prevalent vertebral fractures (24/60 men, 22/44 women). Patients with fractures were not significantly older than patients without fractures (mean +/- SD, 64 +/- 9.2 versus 62 +/- 12.3 years; p=0.4). Trabecular BMD in patients with fractures versus without fractures was 169 +/- 41 versus 192 +/- 51mg/cc (AUC=0.62 +/- 0.06, sOR=1.6 [1.1 to 2.5], p=0.02). Microstructural variables achieved optimal discriminatory power at bone thresholds of 150mg/cc. Best fracture discrimination for single microstructural variables was observed for trabecular separation (Tb.Sp) (AUC=0.72 +/- 0.05, sOR=2.4 (1.5 to 3.9), p<0.0001). In multivariate models AUCs improved to 0.77 +/- 0.05 for BMD and Tb.Sp, and 0.79 +/- 0.05 for Tb.Sp and trabecular thickness (Tb.Th). Compared to BMD values, these improvements of AUC values were statistically significant (p<0.0001). In MM patients, QCT-based analyses of bone structure derived from routine CT scans permit discrimination of patients with and without vertebral fractures. Rarefaction of the trabecular network due to plasma cell infiltration and osteoporosis can be measured. Deterioration of microstructural measures appear to be of value for vertebral fracture risk assessment and may indicate early stages of osteolytic processes not yet visible. (c) 2014 American Society for Bone and Mineral Research.
引用
收藏
页码:1329 / 1337
页数:9
相关论文
共 43 条
[1]
Development of the proteasome inhihitor Veleade™ (Bortezomib) [J].
Adams, J ;
Kauffman, M .
CANCER INVESTIGATION, 2004, 22 (02) :304-311
[2]
Zoledronic acid in the management of bone disease as a consequence of multiple myeloma: a review [J].
Alegre, Adrian ;
Gironella, Mercedes ;
Bailen, Alicia ;
Giraldo, Pilar .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 92 (03) :181-188
[3]
TREATMENT FOR MULTIPLE MYELOMA - COMBINATION CHEMOTHERAPY WITH DIFFERENT MELPHALAN DOSE REGIMENS [J].
ALEXANIAN, R ;
HAUT, A ;
KHAN, AU ;
LANE, M ;
MCKELVEY, EM ;
MIGLIORE, PJ ;
STUCKEY, WJ ;
WILSON, HE .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1969, 208 (09) :1680-+
[4]
Architecture and distribution of cancellous bone yield vertebral fracture clues - A histomorphometric analysis of the complete spinal column from 40 autopsy specimens [J].
Amling, M ;
Posl, M ;
Ritzel, H ;
Hahn, M ;
Vogel, M ;
Wening, VJ ;
Delling, G .
ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 1996, 115 (05) :262-269
[5]
Multiple myeloma: Clinical review and diagnostic imaging [J].
Angtuaco, EJC ;
Fassas, ABT ;
Walker, R ;
Sethi, R ;
Barlogie, B .
RADIOLOGY, 2004, 231 (01) :11-23
[6]
Thalidomide and hematopoietic-cell transplantation for multiple myeloma [J].
Barlogie, B ;
Tricot, G ;
Anaissie, E ;
Shaughnessy, J ;
Rasmussen, E ;
van Rhee, F ;
Fassas, A ;
Zangari, M ;
Hollmig, K ;
Pineda-Roman, M ;
Lee, C ;
Talamo, G ;
Thertulien, R ;
Kiwan, E ;
Krishna, S ;
Fox, M ;
Crowley, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (10) :1021-1030
[7]
Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients [J].
Barlogie, B ;
Desikan, R ;
Eddlemon, P ;
Spencer, T ;
Zeldis, J ;
Munshi, N ;
Badros, A ;
Zangari, M ;
Anaissie, E ;
Epstein, J ;
Shaughnessy, J ;
Ayers, D ;
Spoon, D ;
Tricot, G .
BLOOD, 2001, 98 (02) :492-494
[8]
DIAGNOSIS OF MULTIPLE-MYELOMA [J].
BARTL, R ;
FATEHMOGHADAM, A .
ONKOLOGIE, 1986, 9 (04) :183-195
[9]
Baur-Melnyk A, 2004, RADIOLOGE, V44, P874, DOI 10.1007/s00117-004-1103-z
[10]
Finite element models predict in vitro vertebral body compressive strength better than quantitative computed tomography [J].
Crawford, RP ;
Cann, CE ;
Keaveny, TM .
BONE, 2003, 33 (04) :744-750